IS8548A - Úðaþurrkaðar lyfjablöndur - Google Patents

Úðaþurrkaðar lyfjablöndur

Info

Publication number
IS8548A
IS8548A IS8548A IS8548A IS8548A IS 8548 A IS8548 A IS 8548A IS 8548 A IS8548 A IS 8548A IS 8548 A IS8548 A IS 8548A IS 8548 A IS8548 A IS 8548A
Authority
IS
Iceland
Prior art keywords
spray
pharmaceutical preparations
dried pharmaceutical
dried
preparations
Prior art date
Application number
IS8548A
Other languages
English (en)
Inventor
Andronis Vlasios
Pan Rennan
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of IS8548A publication Critical patent/IS8548A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS8548A 2004-03-30 2006-10-06 Úðaþurrkaðar lyfjablöndur IS8548A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55757104P 2004-03-30 2004-03-30
PCT/US2005/010350 WO2005097077A2 (en) 2004-03-30 2005-03-28 Spray dried pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IS8548A true IS8548A (is) 2006-10-06

Family

ID=34956393

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8548A IS8548A (is) 2004-03-30 2006-10-06 Úðaþurrkaðar lyfjablöndur

Country Status (26)

Country Link
US (1) US20070178151A1 (is)
EP (1) EP1729734B1 (is)
JP (1) JP2007530702A (is)
KR (1) KR20060135000A (is)
CN (1) CN1933816A (is)
AR (1) AR048193A1 (is)
AT (1) ATE387189T1 (is)
AU (1) AU2005231355B2 (is)
BR (1) BRPI0508111A (is)
CA (1) CA2556461A1 (is)
DE (1) DE602005005033T2 (is)
DK (1) DK1729734T3 (is)
ES (1) ES2301003T3 (is)
HR (1) HRP20080154T3 (is)
IL (1) IL177606A0 (is)
IS (1) IS8548A (is)
MA (1) MA28557B1 (is)
NO (1) NO20064864L (is)
NZ (1) NZ549096A (is)
PE (1) PE20060161A1 (is)
PL (1) PL1729734T3 (is)
PT (1) PT1729734E (is)
RU (1) RU2006138054A (is)
TW (1) TW200602055A (is)
WO (1) WO2005097077A2 (is)
ZA (1) ZA200606670B (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506800D0 (en) * 2005-04-04 2005-05-11 Merck Sharp & Dohme New uses
JP2009510099A (ja) * 2005-09-30 2009-03-12 スミスクライン・ビーチャム・コーポレイション 医薬組成物
AR058676A1 (es) * 2005-09-30 2008-02-20 Smithkline Beecham Corp Composicion farmaceutica que contiene (s) -(-)-n-( alfa- etilbencil) -3- hidroxi- 2- fenilquinolina-4-carboxamida ( talnetant), povidona , manitol y tensioactivo, procedimiento para prepararla y forma de dosificacion que la comprende

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
ES2227769T3 (es) * 1994-05-27 2005-04-01 Glaxosmithkline S.P.A. Derivados de quinolina como antagonistas del receptor nk3 de taquiquinina.
US6936277B2 (en) * 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
DE19501269A1 (de) * 1995-01-18 1996-07-25 Henkel Kgaa Amorphes Alkalisilikat-Compound
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US6696084B2 (en) * 2000-09-20 2004-02-24 Rtp Pharma Inc. Spray drying process and compositions of fenofibrate
US6620438B2 (en) * 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
MY134211A (en) * 2001-05-18 2007-11-30 Smithkline Beecham Corp Novel use
EP1443912B1 (en) * 2001-10-12 2007-08-29 Elan Pharma International Limited Compositions having a combination of immediate release and controlled release characteristics

Also Published As

Publication number Publication date
PT1729734E (pt) 2008-05-29
PL1729734T3 (pl) 2008-09-30
EP1729734B1 (en) 2008-02-27
HRP20080154T3 (hr) 2008-10-31
ZA200606670B (en) 2008-01-30
MA28557B1 (fr) 2007-04-03
CN1933816A (zh) 2007-03-21
PE20060161A1 (es) 2006-05-10
BRPI0508111A (pt) 2007-07-17
CA2556461A1 (en) 2005-10-20
AU2005231355A1 (en) 2005-10-20
EP1729734A2 (en) 2006-12-13
KR20060135000A (ko) 2006-12-28
DE602005005033T2 (de) 2009-03-19
TW200602055A (en) 2006-01-16
US20070178151A1 (en) 2007-08-02
AU2005231355B2 (en) 2008-09-18
HK1099213A1 (en) 2007-08-10
ES2301003T3 (es) 2008-06-16
NO20064864L (no) 2006-10-25
JP2007530702A (ja) 2007-11-01
ATE387189T1 (de) 2008-03-15
DE602005005033D1 (de) 2008-04-10
AR048193A1 (es) 2006-04-05
WO2005097077A2 (en) 2005-10-20
DK1729734T3 (da) 2008-06-16
NZ549096A (en) 2009-05-31
RU2006138054A (ru) 2008-05-10
IL177606A0 (en) 2006-12-10
WO2005097077A3 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
MA28489B1 (fr) Preparations pharmaceutiques
NO20075628L (no) Farmasøytiske formuleringer
KR20050009999A (ko) 약제학적 제제
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
IL191759A (en) Ganaxolone formulations and methods for the making and use thereof
EP1784219A4 (en) STABILIZING FORMULATIONS
BRPI0511900A (pt) composições farmacêuticas
FR2889449B1 (fr) Preparations implantables
DE602004017700D1 (de) Transmukosen verabreichung
GB0426301D0 (en) Pharmaceutical formulations
DK1750683T3 (da) Formuleringer med langvarig frigivelse
DK1957073T3 (da) Lægemiddel
EP1732597A4 (en) VACCINE AGAINST STREPTOCOCCUS AGALACTIAE
DK1941798T3 (da) Nematicide præparater
EP1871347A4 (en) PHARMACEUTICAL COMPOSITION
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
ATE546141T1 (de) Pharmazeutisches injektionspräparat
GB0416397D0 (en) Pharmaceutical formulations
DK1809660T3 (da) Thymus-specifikt protein
DK2918286T3 (da) En farmaceutisk formulering
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
DK1729734T3 (da) Spröjtetörrede farmaceutiske præparater
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
SE0601411L (sv) Förfarande vid beredning
FI20040146L (fi) Farmaseuttiset valmisteet